At the ESCMID Global conference in Austria, the development of climate-informed ...
Coherus BioSciences has completed the sale of its Udenyca (pegfilgrastim-cbqv) f...
The FDA will require an additional Phase III trial for apraglutide, the company'...
Valneva has received marketing authorisation from the Brazilian Health Regulator...
Boehringer and Cue Biopharma have entered a strategic research partnership and l...
J&J is projecting a $400m hit due to US tariffs in 2025, but reaffirmed its prof...
In a groundbreaking advancement poised to reshape prognostic assessments in onco...
In a groundbreaking qualitative study published in BMC Cancer, researchers have ...
In the rapidly evolving realm of cancer prognosis, survival analysis stands as a...
A recent groundbreaking study from the Korea Research Institute of Chemical Tech...
Fifty years after its inception, the Endangered Species Act (ESA) stands as a la...
In the relentless pursuit to understand the complex mechanisms driving pancreati...
In the relentless pursuit of advancing cancer diagnostics, researchers have unve...
Cancer continues to pose a formidable challenge to global health, particularly i...
